FindTrial
Sign In

Analgesic effect of anterior quadratus lumborum block at the lumbar 4 level in extensive/sub-wide hysterectomy: a randomized, double-blind, placebo-controlled, single-center clinical trial

Analgesic effect of anterior quadratus lumborum block at the lumbar 4 level in extensive/sub-wide hysterectomy: a randomized, double-blind, placebo-controlled, single-center clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100051848
Enrollment
Unknown
Registered
2021-10-07
Start date
2021-10-15
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anterior quadratus lumborum block at the lumbar 4 level in extensive/sub-wide hysterectomy

Interventions

experimental group:to perform anterior quadratus lumborum block at L4 level bilaterally with 0.375% ropivacaine 20ml
control group:to perform anterior quadratus lumborum block at L4 level bilaterally with 0.9% NaCl 20ml

Sponsors

Affiliated Hospital of Jiangsu University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 65 Years

Inclusion criteria

Inclusion criteria: Aged 45-65 years, body mass index 18-25 kg/m^2, ASA class I-II, can fully understand the research content.

Exclusion criteria

Exclusion criteria: Abnormal heart, liver and kidney function, local anesthetic allergy, contraindication of quadratus lumborum block, chronic pain or receiving chronic pain treatment.

Design outcomes

Primary

MeasureTime frame
Sufentanil dosage 24 hours after surgery;—

Secondary

MeasureTime frame
Intraoperative remifentanil dosage;Postoperative patient-controlled analgesia time;Postoperative pain digital scale score;Heart rate;Mean arterial pressure;—

Countries

China

Contacts

Public ContactWu Jin

Affiliated Hospital of Jiangsu University

wujin914@hotmail.com+86 15905281553

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026